On February 6, Aba Chemicals Corporation(300261) announced that the company had checked the matters related to the abnormal fluctuation of stock trading, the relevant self-examination had been completed, and the trading of the company’s shares would resume from the opening of the market on February 7, 2022.
As soon as the news of the resumption of trading of 4x bull stocks was released, the stock bar immediately quarreled. For tomorrow’s trend, some investors are worried that the share price may be greatly adjusted or even fall by the limit after the resumption of trading, but some investors are still firmly bullish and even boldly predict to continue to rise by the limit.
Source: company announcement
investors have obvious differences
According to the data of China Securities Taurus, from November 1, 2021 to January 14, 2022, Aba Chemicals Corporation(300261) share price began to rush all the way from around 5 yuan. During this period, it once reaped a continuous 20cm limit, with a cumulative increase of 432.55%, becoming one of the most dazzling bull stocks in the recent A-share market.
It is worth noting that Aba Chemicals Corporation(300261) had previously been suspended for a week due to changes in share prices and received letters of regulatory concern. However, after the resumption of trading, the share price soared again, and the trading of the company’s shares was suspended again since the opening of the market on January 17, 2022.
As soon as the news of the resumption of trading of Daniel stocks was released, the stock bar immediately became lively. Some investors predict that the increase in the early stage of Aba Chemicals Corporation(300261) is too large. It is estimated that it will open significantly lower after the resumption of trading, and may even fall by the limit. However, some investors said that the stock is still on the tuyere. The market is optimistic about the prospect of the expansion of carbonic anhydride and is expected to continue to rise after the resumption of trading.
The data show that as of January 28, 2022, Aba Chemicals Corporation(300261) dynamic P / E ratio has reached 130.93 times, far exceeding the industry average. In contrast, the dynamic P / E ratios of Lier Chemical Co.Ltd(002258) , Lianhua technology and Zhejiang Yongtai Technology Co .Ltd(002326) representative comparable listed companies in the same industry are only 14.13 times, 26.28 times and 56.47 times.
In this regard, Aba Chemicals Corporation(300261) reminded again in the announcement that the company’s share price rose sharply in the short term, and the dynamic P / E ratio was higher than the average level of the same industry. The company reminded investors to improve their risk awareness and avoid blindly following the trend.
no Caron anhydride products are supplied to Pfizer
In terms of news, recently Aba Chemicals Corporation(300261) released the news that the company’s carbonic anhydride products and derivatives have achieved commercial mass production. It is speculated that it can be used to synthesize a covid-19 oral drug of Pfizer, causing crazy speculation in the market.
In this regard, Aba Chemicals Corporation(300261) said again in the announcement that the carbonic anhydride and its derivatives refer to compounds, not specifically the products produced by the company. It is impossible to determine that the carbonic anhydride and its derivatives produced by the company can be used to synthesize Pfizer covid-19 oral medicine. The company has no business contact and cooperation with Pfizer, has not signed a cooperation agreement with Pfizer, has not supplied Carlin anhydride products to Pfizer, Pfizer has not provided the company with any quality standards for the procurement of covid-19 oral drug front-end raw materials, and the company’s customers refuse to provide the end use of Carlin anhydride and its derivatives, The company is unable to determine whether the produced carbonic anhydride products meet the needs of Pfizer products, and has not conducted relevant technical verification. It is unable to determine whether the carbonic anhydride products produced by the company are or can become Pfizer covid-19 oral drug intermediates.
the production expansion plan of carbonic anhydride has not been determined
For the expansion plan of carbonic anhydride concerned by the market, Aba Chemicals Corporation(300261) announced that the company learned that other manufacturers in the industry planned to invest in the construction of production lines of carbonic anhydride and its derivatives, and the design capacity was much higher than the company’s existing capacity. According to the scale effect, after other manufacturers put into large-scale production, the production cost is expected to be lower than the production cost of the company’s products, which may lead to the risk of loss of orders, reduction of revenue, decline of profitability and so on. At the same time, the construction and government approval cycle of new chemical production projects is long and uncertain.
In view of the above situation, Aba Chemicals Corporation(300261) said that the company is studying the expansion of production of carbonic anhydride and its derivatives, but has not yet decided whether to expand production, and there is still great uncertainty about whether to expand production in the end. When the downstream market situation of carbonic anhydride and its derivatives becomes clear, the company will make planning and prudent decision on whether to expand production.
In addition, the company also suggests that in recent years, the state and local governments have issued a lot of policies and plans for the chemical industry. There is uncertainty about whether the new chemical (expansion) project can be approved by relevant departments, or whether it can be approved by relevant departments, but the application takes a long time. Therefore, there is still uncertainty about whether the company can expand the production of carbonic anhydride and its derivatives.
